Delivery Order HHSN261201700011I-HHSN26100001

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

This federal contract award with ID HHSN261201700014I|75N91020F00003 was issued by the National Cancer Institute, a civilian federal agency, to the non-profit research organization SRI International. The $37,708.37 cost-plus-fixed-fee contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations, including appearance, proton NMR, infrared, HPLC (assay, impurity), and moisture (KF) testing services. The contract is part of a larger 5-year indefinite delivery vehicle called...

This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to SRI International, a non-profit research and development institute. The $26,166.42 contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations, including tests for appearance, NMR, IR, HPLC, residual solvents, moisture, residue on ignition, and heavy metals for a specific chemical compound, NSC 706744. This contract is part of a larger $26.2 million...

This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for federal...

This contract was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is for $244,349.04 and provides professional and technical support services to the NCI, Center for Cancer Research (CCR), and Product Quality Branch (POB). The contract is a Blanket Purchase Agreement (BPA) call, with a Time and Materials pricing type, and has an ultimate completion date of April 22, 2021. The prime contractor is TAI Pedro...

This is a cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Research Triangle Institute (RTI International), a non-profit research organization. The $17,312,662.00 contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations, and involves the deobligation of funds. The contract does not have a set-aside designation. RTI International, headquartered in...

<p>This is a $1,784.00 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency, to Battelle Memorial Institute for initial administrative charges related to a pre-clinical toxicology study of a drug being developed for cancer patients. The contract is an order placed under the Toxicology of Drugs Developed for Cancer Patients indefinite-delivery indefinite-quantity (IDIQ) contract vehicle. No set-aside was used for this award.</p>

This is a $9,353,817.00 Cost Plus Fixed Fee contract awarded to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), by the National Cancer Institute (NCI) for preclinical toxicology services related to the development of cancer and other therapeutic large molecule drugs. The contract has no set-aside designation. IITRI is an experienced preclinical contract research organization that regularly supports the drug development efforts of federal...

This is a $111,883,041.00 Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI) to Technical Resources International, Inc. (TRI) for drug development support services for the Cancer Therapy Evaluation Program (CTEP). The contract is not set aside. TRI, a minority-owned, woman-owned, and Hispanic American-owned small business, will provide a wide range of drug development support activities to assist NCI in fulfilling its regulatory responsibilities to the FDA. This includes...

This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT). The contract is for the &quot;PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS&quot; under the NCI's PREVENT...